Insights Into the Regulation of Gynecological Inflammation-Mediated Malignancy by Metalloproteinases
Gynecological illness accounts for around 4.5% of the global disease burden, which is higher than other key global health concerns such as malaria (1.04%), TB (1.9%), ischemic heart disease (2.2%), and maternal disorders (3.5%). Gynecological conditions in women of reproductive age are linked to bot...
Guardado en:
Autores principales: | Yasmin Begum, Anuradha Pandit, Snehasikta Swarnakar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e4be654a16f8428ca2673b0d5a0c7959 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Disintegrin and Metalloproteinase 9 Domain (ADAM9) Is a Major Susceptibility Factor in the Early Stages of Encephalomyocarditis Virus Infection
por: Lindsey E. Bazzone, et al.
Publicado: (2019) -
Identification of the Cell-Surface Protease ADAM9 as an Entry Factor for Encephalomyocarditis Virus
por: Jim Baggen, et al.
Publicado: (2019) -
Orosomucoid 1 promotes epirubicin resistance in breast cancer by upregulating the expression of matrix metalloproteinases 2 and 9
por: Luo Qiong, et al.
Publicado: (2021) -
MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
por: Yu. V. Korenovsky, et al.
Publicado: (2012) -
Effect of prostaglandin analogs on matrix metalloproteinases and tissue inhibitor of metalloproteinases in eyelid muscle specimens
por: Karli S, et al.
Publicado: (2018)